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Abstract
Introduction: Pancoast syndrome is characterized by Horner syndrome, shoulder pain radiating down the arm,
compression of the brachial blood vessels, and, in long-standing cases, atrophy of the arm and hand muscles. It is
most commonly associated with lung carcinoma but rarely is seen with certain infections.
Case presentation: We present the case of a 51-year-old Caucasian man who had acute myeloid leukemia and
who developed a rapidly fulminating pneumonia along with signs and symptoms of acute brachial plexopathy and
left Horner syndrome. Also, a purpuric plaque developed over his left chest wall and progressed to skin necrosis.
The skin biopsy and bronchoalveolar lavage showed a Rhizopus species, leading to a diagnosis of mucormycosis.
This is a rare case of pneumonia due to mucormycosis associated with acute Pancoast syndrome.
Conclusions: According to our review of the literature, only a few infectious agents have been reported to be associated
with Pancoast syndrome. We found only three case reports of mucormycosis associated with acute Pancoast syndrome.
Clinicians should consider mucormycosis in their differential diagnosis in a patient with pulmonary lesions and chest wall
invasion with or without neurological symptoms, especially in the setting of neutropenia or other immunosuppressed
conditions. It is important to recognize this condition early in order to target therapy and interventions.
Introduction
Pancoast syndrome is most commonly associated with a
primary lung carcinoma and rarely with metastatic malig-
nancies and certain infections, including mucormycosis.
It is characterized by Horner syndrome, shoulder pain
radiating down the arm, compression of the brachial
blood vessels, and, in long-standing cases, atrophy of the
arm and hand muscles. Pulmonary mucormycosis usually
occurs in the setting of hematological malignancies. The
typical presentation is a patient with neutropenic fever,
pulmonary infiltrates, and a clinical course that worsens
d e s p i t ea n t i b i o t i c s .W ep r e s e n tac a s eo fp u l m o n a r y
mucormycosis associated with postchemotherapy neutro-
penia in a patient with acute myeloid leukemia. His
course was fulminating, leading to chest wall invasion,
brachial plexopathy, and Horner syndrome.
Case presentation
A 51-year-old Caucasian man was hospitalized for the
management of a relapse of acute myeloid leukemia. He
had hyperleukocytosis and complained of mild shortness
of breath and generalized weakness. He denied cough,
fevers or chills, hemoptysis, or orthopnea. He had smoked
39 pack years. His significant medical history began six
months prior to admission, when his condition was diag-
nosed as acute myelomonocytic leukemia. He had been
treated with cytarabine and daunorubicin followed by
high-dose cytarabine. Shortly after admission, he required
urgent leukopheresis because of worsening hyperleukocy-
tosis and acute respiratory failure. He recovered and had
further chemotherapy with clofarabine and cytarabine.
Eighteen days after admission, he was neutropenic and
febrile. He developed left axillary burning pain, which
evolved in a matter of hours to numbness of his arm.
Soon afterward, weakness started in his hand and later
moved proximally up his arm. At that time, he had a tem-
perature of 38°C, a respiratory rate of 20 breaths per min-
ute, a heart rate of 133 beats per minute, blood pressure of
117/77 mm Hg, and an oxygen saturation of 94% on 50%
venturi mask. He was dyspneic and a chest examination
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left lower lobes. A chest radiograph (Figure 1) revealed
elevation of the left hemidiaphragm, alveolar and intersti-
tial opacities of the left upper lobe and lower lobe with air
bronchograms, and blunting of the costophrenic angle. He
was started on broad-spectrum antibiotics and voricona-
zole prophylaxis.
A physical examination revealed edema of the skin over
the anterior left chest wall but no erythema, scaling, or
discrete skin lesions. In a matter of hours, the numbness
spread from a T1 distribution to a C8 distribution. The
following day, his left arm was plegic with the exception
of trace movement of the deltoid muscle. He was anes-
thetic to all sensory modalities in the left arm as well as
areflexic. He also developed a left Horner syndrome.
Further swelling developed in his left arm and anterosu-
perior chest with fullness in the supraclavicular fossa.
Doppler ultrasound showed occlusion of his left distal
subclavian, axillary, and brachial arteries and deep vein
thrombosis of his left internal jugular, subclavian, and
axillary veins. Heparin was started for his thrombosis, but
soon after he had mild hemoptysis. A chest computed
tomography scan (Figure 2) showed extensive edematous
changes of the left chest wall and axilla along with left
pleural effusion and pulmonary parenchymal consolida-
tion. A bronchoscopy that revealed a blood clot in the
left upper lobe bronchus without endobronchial lesions
was performed.
Six days after the onset of numbness, a palpable purpuric
plaque developed over his left chest and progressed to a 2
cm black eschar. A punch biopsy of the plaque was per-
formed. With failure to respond with broad spectrum anti-
biotics (which included vancomycin, imipenem,
voriconazole and acyclovir), liposomal amphotericin B
5 mg/kg per day was added empirically to his regimen. A
histological evaluation of skin biopsy showed abundant
angiocentric and angioinvasive ribbon-like hyphae with
irregular nonparallel contours, occasional right-angle
branching, and rare septae (Figures 3 and 4). Cultures from
both skin and bronchoalveolar lavage confirmed a diagno-
s i so fm u c o r m y c o s i sb yaRhizopus species. Twenty-four
hours later, he developed respiratory distress, shock, and
multiorgan failure resulting in death. An autopsy was
declined by his next of kin.
Figure 1 A chest radiograph shows elevation of the left
hemidiaphragm, alveolar and interstitial opacities of the left
upper lobe and lower lobe with air bronchograms, and
blunting of the costophrenic angle.
Figure 2 Chest computed tomography (CT) image shows
extensive edematous changes of the left chest wall and axilla,
left pleural effusion, and pulmonary parenchymal
consolidation.
Figure 3 Skin biopsy shows invasive fungi (large arrow) in the
nerve (small arrow). The vessel (arrowheads) is filled with hyphae
that are also seen traversing the vessel wall. Numerous hyphae are
seen in the surrounding dermis as well (hematoxylin and eosin
stain).
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Mucormycosis is an uncommon opportunistic infection,
but its incidence is increasing as the number of patients
with diabetes, organ transplants, or immunosuppressed
conditions continues to rise [1]. Hematological malig-
nancies are more frequently associated with mucormy-
cosis than solid tumors are [1]. In patients with
hematological malignancies, mucormycosis affects the
lungs most frequently (58% to 81%) [2].
Pulmonary mucormycosis occurs with inhalation of
spores into the bronchioles and alveoli, usually resulting in
a rapidly progressive pneumonia or endobronchial disease.
Symptoms are typically nonspecific and may include fever,
dyspnea, cough, and chest pain [2,3]. The infection can
spread to contiguous organs or disseminate hematogen-
ously. Of particular interest to our case is the overwhelm-
ing speed with which the process extended from the lung
parenchyma to the surrounding structures (tissue, nerves,
vessels, and skin). The progression of symptoms suggests
that the lower brachial plexus trunk became ischemic initi-
ally and that the rest of the plexus followed as the lesion
extended from the lung to the surrounding tissues. Mucor
is known to locally invade nerves, most often in rhinocer-
ebral disease. Common clinical findings include rhinitis,
periorbital and facial swelling, mucosal necrosis, ophthal-
moplegia, multiple cranial nerve palsies, facial pain, and
headache [4]. Whereas stroke from rhinocerebral mucor-
mycosis causing occlusion of the cavernous portion of the
internal carotid is well documented [4], involvement of
the brachial vascular and nervous plexus is a very unusual
presentation. Three reports document mucormycosis pre-
senting as a Pancoast syndrome [5-7]. Notably, two had
diabetes (both survived) as their only risk factor and one
had acute lymphoblastic leukemia (died).
Pancoast syndrome is characterized by Horner syn-
drome (ptosis, miosis, hemianhidrosis, and enophthal-
mos), shoulder pain radiating toward the axilla or ulnar
aspect of the arm, compression of the brachial blood
vessels, and atrophy of the arm and hand muscles. This
syndrome is most commonly caused by a bronchogenic
carcinoma in the superior sulcus of the lung with
destructive lesions of the thoracic inlet and invasion of
the brachial plexus and cervicothoracic sympathetic
chain. Other causes include metastatic neoplasms and
infections. In a recent review of 31 patients with infec-
tious causes of Pancoast syndrome, five were immuno-
compromised (acute myelogenous leukemia, acute
lymphoblastic leukemia, and postchemotherapy), and all
had opportunistic organisms (Aspergillus spp., mucor,
nocardia, and Pseudoallescheria boydii) [7]. In contrast,
only one of the 26 immunocompetent patients had an
opportunistic organism.
In immunocompromised patients, it can be challen-
ging to distinguish pulmonary disease caused by mucor-
mycosis from that caused by aspergillosis. The
concomitant presence of sinusitis or a history of vorico-
nazole prophylaxis may suggest mucormycosis [8,9]. Of
note, our patient received voriconazole prophylaxis. The
radiographic presentation of pulmonary mucormycosis
can be diverse, and there are no pathognomonic radio-
graphic features. In a review of imaging findings in 32
cases of mucormycosis, two thirds of the patients had
consolidation as a main finding [10]. Other radiographic
manifestations include cavitation, mass-like lesions,
widened mediastinum, an “air crescent sign”, “halo
sign”, pleural effusion, and fistula to the chest wall
[10,11]. Chamilos and colleagues [8], in a retrospective
chart review, found that multiple nodules (at least 10)
and the presence of pleural effusion were more often
found in mucormycosis than in aspergillosis.
Definitive diagnosis of mucormycosis often evades
initial noninvasive techniques such as sputum and blood
cultures. The organism may be recovered by broncho-
scopy with bronchoalveolar lavage or transbronchial
lung biopsy. However, because of the focal distribution
of the disease, transthoracic computed tomography-
guided needle biopsy or open lung biopsy may be
required to make the diagnosis in pulmonary disease
[1,12,13]. Histology is characterized by infarction and
necrosis of tissue which results from an invasion of the
vasculature by hyphae. The fungus can also be asso-
ciated with neural, vascular, and cutaneous invasion, as
in our patient. The fungus is usually recognized by
broad, irregular, nonseptate, right-angled, branching
hyphae and is demonstrated by hematoxylin and eosin
and specialized fungal stains. In contrast, Aspergillus
hyphae are narrow with septate branches at 45° angles.
Figure 4 Skin biopsy shows numerous fungi with broad
hyphae, with right-angle branching (hematoxylin and eosin
stain).
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Treatment of mucormycosis involves a combination of
surgical debridement of involved tissues and antifungal
therapy with varying degrees of success, as noted in the
literature [1,14,15]. Amphotericin B is the first-line anti-
fungal treatment; delays in instituting therapy may be
associated with increased mortality. Elimination of pre-
disposing factors for infection, such as hyperglycemia,
metabolic acidosis, and neutropenia, is critical. Pulmon-
ary mucormycosis carries a very high mortality rate
(60% to 90%) [1,14].
Conclusions
It is important to consider the diagnosis of mucormyco-
sis in a patient with pulmonary lesions and chest wall
invasion with or without neurological symptoms, espe-
cially in the setting of neutropenia or other immunosup-
pressed conditions. Our patient had a rapid progression
to multiorgan failure and refractory shock despite being
treated with amphotericin B and died within two days
of his diagnosis.
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